Literature DB >> 3711091

Primary structure of limulus anticoagulant anti-lipopolysaccharide factor.

J Aketagawa, T Miyata, S Ohtsubo, T Nakamura, T Morita, H Hayashida, T Miyata, S Iwanaga, T Takao, Y Shimonishi.   

Abstract

A potent anticoagulant, anti-lipopolysaccharide (LPS) factor, found in limulus hemocytes inhibits the LPS-mediated activation of limulus coagulation cascade and shows an antibacterial action against R-types of Gram-negative bacteria (Morita, T., Ohtsubo, S., Nakamura, T., Tanaka, S., Iwanaga, S., Ohashi, K., and Niwa, M. (1985) J. Biochem. (Tokyo) 97, 1611-1620). The complete amino acid sequence of this substance was determined by sequencing the peptides obtained by selective proteolytic cleavage. The NH2-terminal end of anti-LPS factor was pyroglutamic acid. Anti-LPS factor had two variant residues at position 36 and the COOH-terminal end, respectively. The following sequence was assigned to anti-LPS factor, and it was also confirmed by fast atom bombardment mass spectrometry. less than EGGIWTQLALALVKNLATLWQSGDFQFLGHE (formula; see text) Limulus anti-LPS factor consisted of a single chain of 102 residues with 2 half-cystines in disulfide linkage. Its NH2-terminal region up to 20 residues was highly hydrophobic, and positively charged residues were clustered mainly within the disulfide loop. By searching the homologous sequence in known protein sequences with that of anti-LPS factor, we found a structural homology between anti-LPS factor and alpha-lactalbumin/lysozyme family.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

Review 2.  Antimicrobial peptides from marine invertebrates.

Authors:  J Andy Tincu; Steven W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

3.  Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.

Authors:  H S Warren; M L Glennon; N Wainwright; S F Amato; K M Black; S J Kirsch; G R Riveau; R I Whyte; W M Zapol; T J Novitsky
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane.

Authors:  P Viljanen; P Koski; M Vaara
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

5.  New aspects in the treatment of gram-negative bacteraemia and septic shock.

Authors:  I Schedel
Journal:  Infection       Date:  1988       Impact factor: 3.553

6.  Roles of the clip domains of two protease zymogens in the coagulation cascade in horseshoe crabs.

Authors:  Keisuke Yamashita; Toshio Shibata; Toshiaki Takahashi; Yuki Kobayashi; Shun-Ichiro Kawabata
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

7.  Antilipopolysaccharide factor from horseshoe crab, Tachypleus tridentatus, inhibits lipopolysaccharide activation of cultured human endothelial cells.

Authors:  C E Desch; P O'Hara; J M Harlan
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

8.  Anti-lipopolysaccharide factors in the American lobster Homarus americanus: molecular characterization and transcriptional response to Vibrio fluvialis challenge.

Authors:  K M Beale; D W Towle; N Jayasundara; C M Smith; J D Shields; H J Small; S J Greenwood
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2008-12       Impact factor: 2.674

Review 9.  Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae.

Authors:  Valerie J Smith; Andrew P Desbois; Elisabeth A Dyrynda
Journal:  Mar Drugs       Date:  2010-04-14       Impact factor: 5.118

10.  Lipopolysaccharide-binding proteins of Limulus amebocyte lysate.

Authors:  R I Roth; P S Tobias
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.